Abstract
There is a belief among methadone patients that triple therapy for HIV reduces methadone potency. This cross-sectional study compared the rate of methadone metabolism (peak-trough blood levels) in two groups of methadone-maintained patients, AIDS patients receiving triple therapy (N = 17), and HIV patients without triple therapy (N = 19). These preliminary findings suggest that triple therapy may increase the rate of methadone metabolism, though further studies are warranted.
Publication types
-
Clinical Trial
-
Comparative Study
MeSH terms
-
Acquired Immunodeficiency Syndrome / complications
-
Acquired Immunodeficiency Syndrome / drug therapy
-
Adolescent
-
Adult
-
Aged
-
Anti-HIV Agents / administration & dosage
-
Anti-HIV Agents / therapeutic use*
-
Cross-Sectional Studies
-
Drug Interactions
-
Drug Therapy, Combination
-
Female
-
HIV Infections / complications
-
HIV Infections / drug therapy*
-
Heroin Dependence / complications
-
Heroin Dependence / rehabilitation*
-
Humans
-
Male
-
Methadone / blood*
-
Methadone / pharmacokinetics
-
Methadone / therapeutic use*
-
Middle Aged
Substances
-
Anti-HIV Agents
-
Methadone